NovaBay introduces new eye care product in US

Biopharmaceutical firm NovaBay Pharmaceuticals has launched a new eye care product, i-Lid Cleanser, at the American Society of Cataract and Refractive Surgery in the US.

The eye care product is said to have cleared FDAs 510(k) process and helps people with eyelid irritation by cleaning their lids and lashes and removing debris as well as microorganisms, which often cause vision related issues.

According to the company, the product can be used not only for the eyelids but also for the skin around the eyes.

NovaBay Advanced i-Lid Cleanser contains stabilised form of hypochlorous acid solution, which was made from a proprietary formulation to make it more stable and free from impurities, compared to hypochlorous acid made by the body’s white blood cells.

The company claims that the hypochlorous acid solution has fast action against bacteria, biofilm and toxins.

NovaBay Pharmaceuticals chief executive officer and chairman Ron Najafi said: "We believe ophthalmologists and optometrists will find that NovaBay’s innovative Advanced i-Lid Cleanser offers significant advantages over currently marketed products that are merely ‘detergent-based’ lid and lash cleaners, which offer little to no benefit."

Surveys of eye doctors reveal that over 3% of ophthalmic patients suffer from inflammation of the eyelid, which is treated by recommending careful cleaning of the lid and lash margin with warm compress and mild soap.

The company said in a statement that the NovaBay’s i-Lid Cleanser should be used under the supervision of ophthalmologists, optometrists and other healthcare providers.